Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
In 2021, semaglutide was approved by the FDA for chronic weight management in adults with obesity (body mass index of 30 kilograms per square meter (kg/m2) or greater) or overweight (body mass index of 27 kg/m2 or greater) under the brand name Wegovy
Gault V, Porter W, Flatt P, et al
When you are overweight, you can become less sensitive to insulin
Ongoing care and support
In comparison, a small molecule like orforglipron is a roughly 16-step convergent organic synthesis from common starting materials (see, e.g., Part I and Part II of a key intermediate synthesis from the Lilly process team)
Key Mechanistic Differences# Dosing Comparison# Retatrutide Dosing# In the Phase 2 trial, retatrutide was administered as once-weekly subcutaneous injections
US$ 23.94
US$ 21.75
US$ 26.58
US$ 21.00
US$ 21.11
US$ 27.72
US$ 20.90
US$ 29.95
